Intranasal Administration for Pain: Oxytocin and Other Polypeptides
Pain, particularly chronic pain, remains one of the most debilitating and difficult-to-treat conditions in medicine. Chronic pain is difficult to treat, in part because it is associated with plastic changes in the peripheral and central nervous systems. Polypeptides are linear organic polymers that...
Main Authors: | Vimala N. Bharadwaj, Alexander Z. Tzabazis, Michael Klukinov, Neil A. Manering, David C. Yeomans |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/7/1088 |
Similar Items
-
Ameliorating Impact of Prophylactic Intranasal Oxytocin on Signs of Fear in a Rat Model of Traumatic Stress
by: Micah D. Renicker, et al.
Published: (2018-05-01) -
Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system
by: McGowan JWD, et al.
Published: (2016-09-01) -
Elevated salivary levels of oxytocin persist more than seven hours after intranasal administration
by: Marinus H. Van IJzendoorn, et al.
Published: (2012-12-01) -
Increased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs
by: Andrea Temesi, et al.
Published: (2017-09-01) -
Intranasal Oxytocin Failed to Affect Chimpanzee (Pan troglodytes) Social Behavior
by: Darby Proctor, et al.
Published: (2016-08-01)